These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Cheng-Prusoff relationship: something lost in the translation. Craig DA Trends Pharmacol Sci; 1993 Mar; 14(3):89-91. PubMed ID: 8488569 [TBL] [Abstract][Full Text] [Related]
3. Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation. Lazareno S; Birdsall NJ Trends Pharmacol Sci; 1993 Jun; 14(6):237-9. PubMed ID: 8372404 [TBL] [Abstract][Full Text] [Related]
4. Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations. Lazareno S; Birdsall NJ Br J Pharmacol; 1993 Aug; 109(4):1110-9. PubMed ID: 8401922 [TBL] [Abstract][Full Text] [Related]
5. Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation. Ezechiáš M; Cajthaml T Toxicology; 2019 May; 420():21-28. PubMed ID: 30935971 [TBL] [Abstract][Full Text] [Related]
6. Problems associated with the application of the Cheng-Prusoff relationship to estimate atropine affinity constants using functional tissue responses. Eglen RM; Whiting RL Life Sci; 1989; 44(1):81-94. PubMed ID: 2913438 [TBL] [Abstract][Full Text] [Related]
7. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations. Cheng HC Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026 [TBL] [Abstract][Full Text] [Related]
8. Assessing receptor affinity for inverse agonists: Schild and Cheng-Prusoff methods revisited. Giraldo J; Serra J; Roche D; Rovira X Curr Drug Targets; 2007 Jan; 8(1):197-202. PubMed ID: 17266542 [TBL] [Abstract][Full Text] [Related]
9. The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations. Cheng HC J Pharmacol Toxicol Methods; 2001; 46(2):61-71. PubMed ID: 12481843 [TBL] [Abstract][Full Text] [Related]
10. An alternative method to evaluate the nature of an antagonist and its potency: a theoretical approach. Calderone V J Pharmacol Toxicol Methods; 1998 Apr; 39(3):129-35. PubMed ID: 9741386 [TBL] [Abstract][Full Text] [Related]
11. Experimental and theoretical comparisons between the classical Schild analysis and a new alternative method to evaluate the pA2 of competitive antagonists. Calderone V; Baragatti B; Breschi MC; Martinotti E Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):477-87. PubMed ID: 10598787 [TBL] [Abstract][Full Text] [Related]
12. How we describe competitive antagonists: three questions of usage. Jenkinson DH Trends Pharmacol Sci; 1991 Feb; 12(2):53-4. PubMed ID: 2024288 [TBL] [Abstract][Full Text] [Related]
13. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions. Kenakin TP Mol Pharmacol; 1992 Apr; 41(4):699-707. PubMed ID: 1569922 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Apparent Noncompetitive Responses to Competitive H(1)-Histamine Receptor Antagonists in Fluorescent Imaging Plate Reader-Based Calcium Assays. Miller TR; Witte DG; Ireland LM; Kang CH; Roch JM; Masters JN; Esbenshade TA; Hancock AA J Biomol Screen; 1999; 4(5):249-258. PubMed ID: 10838445 [TBL] [Abstract][Full Text] [Related]
15. An exact correction to the "Cheng-Prusoff" correction. Munson PJ; Rodbard D J Recept Res; 1988; 8(1-4):533-46. PubMed ID: 3385692 [TBL] [Abstract][Full Text] [Related]
16. How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated? MacKay D J Pharm Pharmacol; 1978 May; 30(5):312-3. PubMed ID: 26747 [No Abstract] [Full Text] [Related]
17. Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants. Leff P; Martin GR; Morse JM Br J Pharmacol; 1985 Jul; 85(3):655-63. PubMed ID: 4027483 [TBL] [Abstract][Full Text] [Related]
18. The Schild regression in the process of receptor classification. Kenakin TP Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056 [TBL] [Abstract][Full Text] [Related]
19. Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant. Black JW; Gerskowitch VP; Leff P; Shankley NP Br J Pharmacol; 1986 Nov; 89(3):547-55. PubMed ID: 2432983 [TBL] [Abstract][Full Text] [Related]
20. A history of James Craig's hall for the Royal College of Physicians of Edinburgh. Lewis AR J R Coll Physicians Edinb; 2008 Jun; 38(2):172-8. PubMed ID: 18831117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]